NW FL Clinical Research Group, LLC

Gulf Breeze, Florida 32561-4458

4 studies enrolling now · 26 studies all time

What they study most

Cerebral Palsy, Chronic Migraine in Children, Developmental and Epileptic Encephalopathy, Dravet Syndrome, Duchenne Muscular Dystrophy (DMD), Epilepsy, Epilepsy With Simple or Complex Partial Onset Seizures, Migraine, Migraine Disorders, Migraine in Children, Muscle Spasticity, Muscular Dystrophy, Duchenne

Studies at this site

• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine — Recruiting now
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine — Recruiting now
• A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder — Running, not enrolling
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — Enrolling by invitation
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — Running, not enrolling
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults — Completed
• An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome — Completed
• An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen) — Stopped early
• A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab — Completed
• A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome — Completed
• Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity — Completed
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD) — Completed
• Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy — Stopped early
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• Study of Eteplirsen in DMD Patients — Completed
• BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity — Completed
• BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity — Completed
• BOTOX® Treatment in Pediatric Upper Limb Spasticity — Completed
• BOTOX® Treatment in Pediatric Lower Limb Spasticity — Completed
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
• Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults — Completed
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine — Completed
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed